Global IVD Leader SSI Diagnostica Group operates as a global powerhouse in infectious disease diagnostics with production facilities in San Diego, Virginia, Beijing, and Hillerød and a broad distribution network, presenting multiple entry points for sales of IVD kits, culture media, and diagnostic consumables.

Acquisition Opportunity Recent acquisition of InDevR expands capabilities in multiplexed vaccine testing and quality control, signaling potential upsell of advanced diagnostic and QC solutions to vaccine manufacturers and contract development organizations.

Diverse Disease Coverage Focused expertise across gastric, respiratory, and bloodborne diseases creates cross-selling potential for integrated diagnostic panels, ELISA/EIA platforms, lateral flow tests, and related consumables to hospitals, clinics, and reference labs.

Regulatory Readiness ISO 13485 certification across sites with ongoing IVDR alignment indicates a framework that can accelerate new product introductions and clarity for customers needing compliant IVD solutions in various regions.

Growth and Scale Revenue tier of 10 to 25 million USD with multiple sites and a history of collaboration with vaccine and outbreak monitoring partners suggests opportunities to position SSI Diagnostica for mid-market to enterprise deals, especially with labs seeking end-to-end diagnostic portfolios.